Clinical Trial Update: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of Cetrotide acetate (cetrorelix acetate) to prevent ovarian hyperstimulation syndrome in oocyte donors; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CETROTIDE (cetrorelix acetate)

Snippet

Sponsor: Virginia Center for Reproductive Medicine | Conditions: Ovarian Hyperstimulation Syndrome | NA | Status: COMPLETED | Results posted: 2013-03-27